Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1986 1
1987 1
1995 1
1997 1
2000 2
2007 1
2008 5
2010 5
2011 3
2012 9
2013 9
2014 8
2015 10
2016 5
2017 12
2018 22
2019 21
2020 6
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 31988269

105 results
Results by year
Filters applied: . Clear all
Page 1
Mechanisms of Metabolic Acidosis-Induced Kidney Injury in Chronic Kidney Disease.
Wesson DE, Buysse JM, Bushinsky DA. Wesson DE, et al. J Am Soc Nephrol. 2020 Mar;31(3):469-482. doi: 10.1681/ASN.2019070677. Epub 2020 Jan 27. J Am Soc Nephrol. 2020. PMID: 31988269
Effect of oral sodium bicarbonate supplementation on progression of chronic kidney disease in patients with chronic metabolic acidosis: study protocol for a randomized controlled trial (SoBic-Study).
Gaggl M, Cejka D, Plischke M, Heinze G, Fraunschiel M, Schmidt A, Hörl WH, Sunder-Plassmann G. Gaggl M, et al. Trials. 2013 Jul 4;14:196. doi: 10.1186/1745-6215-14-196. Trials. 2013. PMID: 23826760 Free PMC article. Clinical Trial.
Urine citrate excretion as a marker of acid retention in patients with chronic kidney disease without overt metabolic acidosis.
Goraya N, Simoni J, Sager LN, Madias NE, Wesson DE. Goraya N, et al. Kidney Int. 2019 May;95(5):1190-1196. doi: 10.1016/j.kint.2018.11.033. Epub 2019 Mar 1. Kidney Int. 2019. PMID: 30846270
Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate.
Goraya N, Simoni J, Jo CH, Wesson DE. Goraya N, et al. Kidney Int. 2014 Nov;86(5):1031-8. doi: 10.1038/ki.2014.83. Epub 2014 Apr 2. Kidney Int. 2014. PMID: 24694986 Free article. Clinical Trial.
Does oral sodium bicarbonate therapy improve function and quality of life in older patients with chronic kidney disease and low-grade acidosis (the BiCARB trial)? Study protocol for a randomized controlled trial.
Witham MD, Band MM, Littleford RC, Avenell A, Soiza RL, McMurdo ME, Sumukadas D, Ogston SA, Lamb EJ, Hampson G, McNamee P; BiCARB Study Group. Witham MD, et al. Trials. 2015 Aug 1;16:326. doi: 10.1186/s13063-015-0843-6. Trials. 2015. PMID: 26231610 Free PMC article. Clinical Trial.
Acid-base status and progression of chronic kidney disease.
Goraya N, Wesson DE. Goraya N, et al. Curr Opin Nephrol Hypertens. 2012 Sep;21(5):552-6. doi: 10.1097/MNH.0b013e328356233b. Curr Opin Nephrol Hypertens. 2012. PMID: 22874469 Review.
Tolerance to Sodium in Patients With CKD-Induced Metabolic Acidosis: Does the Accompanying Anion Matter?
Bushinsky DA. Bushinsky DA. Am J Kidney Dis. 2019 Jun;73(6):858-865. doi: 10.1053/j.ajkd.2018.09.004. Epub 2018 Dec 3. Am J Kidney Dis. 2019. PMID: 30518477 Free article. Review.
Does correction of metabolic acidosis slow chronic kidney disease progression?
Goraya N, Wesson DE. Goraya N, et al. Curr Opin Nephrol Hypertens. 2013 Mar;22(2):193-7. doi: 10.1097/MNH.0b013e32835dcbbe. Curr Opin Nephrol Hypertens. 2013. PMID: 23380803 Review.
Acute and chronic effects of metabolic acidosis on renal function and structure.
Tammaro G, Zacchia M, Zona E, Zacchia E, Capasso G. Tammaro G, et al. J Nephrol. 2018 Aug;31(4):551-559. doi: 10.1007/s40620-018-0493-3. Epub 2018 Apr 26. J Nephrol. 2018. PMID: 29700802
Acid retention accompanies reduced GFR in humans and increases plasma levels of endothelin and aldosterone.
Wesson DE, Simoni J, Broglio K, Sheather S. Wesson DE, et al. Am J Physiol Renal Physiol. 2011 Apr;300(4):F830-7. doi: 10.1152/ajprenal.00587.2010. Epub 2011 Jan 26. Am J Physiol Renal Physiol. 2011. PMID: 21270096 Free article.
105 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback